Farms.com Home   News

CIMMYT and NOVO Nordisk Foundation Expand Collaboration to Drive Sustainable Agriculture

Building on the success of their initial project, CropSustaiN, CIMMYT and the Novo Nordisk Foundation are proud to announce an expanded partnership aimed at tackling agriculture’s biggest challenges. This enhanced collaboration will broaden efforts to transform farming practices, reduce environmental impacts, and support farmers worldwide.

From specific solutions to a broader vision:
The initial partnership focused on developing innovative wheat varieties through Biological Nitrification Inhibition (BNI), significantly reducing the need for nitrogen fertilizers. Now, this expanded collaboration sets a foundation for exploring a wider range of initiatives, including:

  • Climate-smart crop systems with reduced greenhouse gas emissions.
  • Advanced agricultural technologies for greater resilience and sustainability.
  • Inclusive tools to empower farmers globally.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.